SI1389213T1 - 3,7-diazabiciklo(3.3.1)formulacije kot antiaritmicne spojine - Google Patents

3,7-diazabiciklo(3.3.1)formulacije kot antiaritmicne spojine

Info

Publication number
SI1389213T1
SI1389213T1 SI200230325T SI200230325T SI1389213T1 SI 1389213 T1 SI1389213 T1 SI 1389213T1 SI 200230325 T SI200230325 T SI 200230325T SI 200230325 T SI200230325 T SI 200230325T SI 1389213 T1 SI1389213 T1 SI 1389213T1
Authority
SI
Slovenia
Prior art keywords
antiarhythmic
diazabicyclo
formulations
compounds
antiarhythmic compounds
Prior art date
Application number
SI200230325T
Other languages
English (en)
Inventor
Neil Barnwell
Annika Bjoere
Lal Cheema
David Cladingboel
Adam Herring
Karin Loevqvist
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE0101327A external-priority patent/SE0101327D0/xx
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of SI1389213T1 publication Critical patent/SI1389213T1/sl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/08Bridged systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
SI200230325T 2001-04-12 2002-04-12 3,7-diazabiciklo(3.3.1)formulacije kot antiaritmicne spojine SI1389213T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE0101327A SE0101327D0 (sv) 2001-04-12 2001-04-12 New crystalline forms
PCT/SE2002/000725 WO2002083688A1 (en) 2001-04-12 2002-04-12 3,7-diazabicyclo [3.3.1] formulations as antiarhythmic compounds
EP02761972A EP1389213B1 (en) 2001-04-12 2002-04-12 3,7-diazabicyclo 3.3.1| formulations as antiarhythmic compounds

Publications (1)

Publication Number Publication Date
SI1389213T1 true SI1389213T1 (sl) 2006-08-31

Family

ID=34575658

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200230325T SI1389213T1 (sl) 2001-04-12 2002-04-12 3,7-diazabiciklo(3.3.1)formulacije kot antiaritmicne spojine

Country Status (1)

Country Link
SI (1) SI1389213T1 (sl)

Similar Documents

Publication Publication Date Title
MXPA03008275A (es) Formulas antibacteriales.
MXPA03009558A (es) Compuestos novedosos.
HK1051193A1 (en) (1,4')-Bipiperidine compounds.
MXPA03007093A (es) Nueva composicion.
MXPA03008961A (es) Composicion de vacuna.
AU4787301A (en) 26,27-homologated-20-epi-2-alkyl-19-nor-vitamin d compounds
MXPA03009361A (es) Compuestos de urea utilies como agentes anti-inflamatorios.
HK1061026A1 (en) 3,7-Diazabicyclo 3.3.1Ü formulations as antiarhythmic compounds
MXPA03009698A (es) Vacuna multivalente que comprende un antigeno vih y un antigeno vsh y/o un antigeno vph.
ZA200302929B (en) Compositions comprising cyclohexamantane.
MXPA03007693A (es) Composicion para la piel.
ZA200206779B (en) Solid formulation.
EG23378A (en) Composition.
MXPA03002117A (es) Composiciones fungicidas.
MXPA03001263A (es) Formulacion fungicida.
IL162310A0 (en) 3,4-Dihydro-1h-isoquinoloin-2-yl-derivatives
IL158033A0 (en) 3, 7-diazabicyclo [3.3.1] formulations as anti-arrhythmic compounds
ZA200403323B (en) Anthelmintic composition.
IL158035A0 (en) 3, 7-diazabicyclo [3.3.1] formulations as antiarrhythmic compounds
MXPA03008077A (es) Composicion humedecedora para la piel..
ZA200110500B (en) Pharmaceutical composition.
SI1389213T1 (sl) 3,7-diazabiciklo(3.3.1)formulacije kot antiaritmicne spojine
HK1057551A1 (en) Substituted 3,4-dihydro-pyridoÄ1,2-AÜpyrimidines.
MXPA03007318A (es) Composicion farmaceutica.
PT1497256E (pt) Compostos de 1,5-diaminopentan-3-ol substituídos